4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-023020
Chief Commercial Officer sold 2,598 shares at $3.70 ($9,615)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ludwig Jeffrey Jerome Chief Commercial Officer | 2024-07-17 | Sale 10b5-1 | −2,598 | $3.70 | $9,615 | 118,388 | D |
| Open-market sales · 2,598 sh · avg $3.70 · $9,615 | |||||||
Loading xslF345X05/rdgdoc.xml…